Citation

Discussion Paper Details

Please find the details for DP8367 in an easy to copy and paste format below:

Full Details   |   Bibliographic Reference

Full Details

Title: Market Size and Pharmaceutical Innovation

Author(s): Oliver de Mouzon, Pierre Dubois, Fiona Scott Morton and Paul Seabright

Publication Date: April 2011

Keyword(s): elasticity, innovation, market size and pharmaceuticals

Programme Area(s): Industrial Organization

Abstract: This paper quantifies the relationship between market size and innovation in the pharmaceutical industry. We estimate the elasticity of innovation, as measured by the number of new chemical entities appearing on the market for a given disease class, to the potential market size represented by the willingness of sufferers of diseases in that class (and others acting on their behalf such as insurers and governments) to spend on their treatment during the patent lifetime. We find positive significant elasticities with a point estimate under our preferred specification of 25.2%. This suggests that at the mean market size an additional $1.8 billion is required in additional patent life revenue to induce the invention of one additional new chemical entity. An elasticity substantially and significantly below one-half is also a plausible implication of the hypothesis that innovation in pharmaceuticals is becoming more difficult and expensive over time, as costs of regulatory approval rise and as the industry runs out of "low hanging fruit."

For full details and related downloads, please visit: https://cepr.org/active/publications/discussion_papers/dp.php?dpno=8367

Bibliographic Reference

de Mouzon, O, Dubois, P, Scott Morton, F and Seabright, P. 2011. 'Market Size and Pharmaceutical Innovation'. London, Centre for Economic Policy Research. https://cepr.org/active/publications/discussion_papers/dp.php?dpno=8367